Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
daniele.santini@uniroma1.it
Daniele Santini
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
daniele.santini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
CLINICAL CANCER RESEARCH
2024
Assessing risks and knowledge gaps on the impact of systemic therapies in early breast cancer on female fertility: A systematic review of the literature
CANCER TREATMENT REVIEWS
2024
Blood Extracellular Vesicles beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients
BIOMEDICINES
2024
Real-Life Comparative Analysis of Robotic-Assisted Versus Laparoscopic Radical Prostatectomy in a Single Centre Experience
CANCERS
2024
Protein corona on nanoparticles for tumor targeting in prostate cancer. Review of the literature and experimental trial protocol
BIOLOGY
2024
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients
FRONTIERS IN IMMUNOLOGY
2024
Sjögren syndrome induced by anti PDL-1 treatment for TNBC: case report and review of literature
FRONTIERS IN IMMUNOLOGY
2024
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer
FRONTIERS IN ONCOLOGY
2023
NmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives
CANCER TREATMENT REVIEWS
2023
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management
FRONTIERS IN ONCOLOGY
2023
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer
CELLS
2023
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma
LUNG CANCER
2023
Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study
CANCERS
2023
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer
CLINICAL CANCER RESEARCH
2023
Standardization of Body Composition Status in Patients with Advanced Urothelial Tumors: The Role of a CT-Based AI-Powered Software for the Assessment of Sarcopenia and Patient Outcome Correlation
CANCERS
2023
Palliative sedation and time to death in home palliative care: retrospective analysis
BMJ SUPPORTIVE & PALLIATIVE CARE
2023
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors
FRONTIERS IN IMMUNOLOGY
2023
Network approach in liquidomics landscape
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2023
Early impairment of food intake in patients newly diagnosed with cancer
FRONTIERS IN NUTRITION
2023
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY
2023
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
…
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma